RYAN WESLEY FLOYD
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care PACE, FL NPI 1538676366
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care FL Novo Nordisk AS All categories
General Payments — all program years on this page
$719.85
- Category: General Payments
- Program years: PY2021–2023
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $202.19 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $202.19 | 10 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $59.19 | 3 |
| ABBVIE INC. | $52.74 | 3 |
| PFIZER INC. | $37.32 | 2 |
| Astellas Pharma US Inc | $28.44 | 1 |
| DEXCOM, INC. | $24.50 | 1 |
By program year
Records — PY2023 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1001651317 | Novo Nordisk Inc | $15.88 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1001651327 | Novo Nordisk Inc | $20.41 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1001651337 | Novo Nordisk Inc | $22.90 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1004074775 | ABBVIE INC. | $20.32 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1004074783 | ABBVIE INC. | $17.23 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1004074789 | ABBVIE INC. | $15.19 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1034249665 | Astellas Pharma US Inc | $28.44 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1049181191 | PFIZER INC. | $20.04 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050296733 | PFIZER INC. | $17.28 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1054637623 | Dexcom, Inc. | $24.50 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.